BIAF bioAffinity Technologies, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon days Filed Jun 16, 2026 Processed 4d 19h ago SEC 0001493152-26-028823
8-K context-dependent: Items 8.01
Latest settled — T+1d ⚠ clustered
BIAF ▼ -11.96% at T+1d
NEUTRAL call ✗ call lost -11.96% · α vs SPY -10.71% · entry $0.9448 → $0.8318
Next anchor: T+5d in 3d
Last close $0.8370 (close Jun 18) · -11.41% from $0.9448 entry
Entry anchored
Jun 16, 08:19 AM ET
via Databento tick
T+1d
-11.96%
call -11.96% · α -10.71%
$0.8318
settled 4d ago
T+5d
call — · α —
in 3d
T+20d
call — · α —
in 24d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

bioAffinity Technologies announced a July 21, 2026 webinar on veteran lung health screening, co-hosted with Philips, 4DMedical, and NAVREF. The event features clinical experts discussing CyPath Lung, mobile CT, and functional lung imaging. This is a routine educational/promotional event with no financial terms or material business developments disclosed.

Actionable Insight

Monitor the July 21 webinar for any clinical adoption or partnership announcements, but this filing alone provides no immediate trading catalyst. The company's $6M market cap and lack of revenue visibility suggest continued speculative risk.

Key Facts

  • Webinar scheduled for July 21, 2026, hosted by NAVREF
  • Panel includes Philips, bioAffinity (CyPath Lung), and 4DMedical
  • CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in published trial
  • No financial terms, partnership agreements, or revenue guidance disclosed

Financial Impact

No financial figures reported in the filing

Risk Factors

  • No material financial or operational update — stock may remain range-bound
  • Low institutional ownership and minimal analyst coverage limit price catalysts

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028823
Exhibit: ex99-1.htm0001493152-26-028823
Document: 0001493152-26-028823-index-headers.html0001493152-26-028823
Document: 0001493152-26-028823-index.html0001493152-26-028823
Document: 0001493152-26-028823.txt0001493152-26-028823
7 reports for BIAF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BIAF — sortable, filterable
Type Now
Jun 18, 2026
2d ago
424B4
BEARISH ★ 7/10
$0.8569 awaiting T+1awaiting T+1$0.8370 (+2.32%)
Jun 17, 2026
4d ago
EFFECT
BEARISH ★ 7/10
$0.8318 $0.8372▼ −0.65%▲ +0.13%$0.8370 (−0.63%)
Jun 16, 2026
4d ago
S-1/A
NEUTRAL ★ 3/10
$0.8318 $0.8372▲ +0.65%▼ −0.13%$0.8370 (+0.63%)
Jun 16, 2026
4d ago
8-K
NEUTRAL ★ 2/10
$0.9448 $0.8318▼ −11.96%▼ −10.71%$0.8370 (−11.41%)
Jun 12, 2026
8d ago
S-1
BEARISH ★ 6/10
$1.37 $0.9448▲ +31.04%▲ +30.44%$0.8370 (+38.91%)
Mar 3, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$1.03 $1.03· 0.00%▲ +0.57%$0.8370 (−18.74%)
Feb 25, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$1.09 $1.04▼ −4.59%▼ −4.04%$0.8370 (−23.21%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (29h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access